Cargando…

Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study

Whether non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiovascular events (CVEs) independently from metabolic syndrome (MetS) is still matter of debate. Aim of the study was to investigate the risk of CVEs in a high-risk population of patients with non-valvular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pastori, Daniele, Sciacqua, Angela, Marcucci, Rossella, Del Ben, Maria, Baratta, Francesco, Violi, Francesco, Pignatelli, Pasquale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Im - Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563662/ https://www.ncbi.nlm.nih.gov/pubmed/33713286 http://dx.doi.org/10.1007/s11739-021-02682-3

Ejemplares similares

SARS-CoV-2 and myocardial injury: a role for Nox2?
por: Violi, Francesco, et al.
Publicado: (2020)

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
por: Pastori, Daniele, et al.
Publicado: (2018)

Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms
por: Violi, Francesco, et al.
Publicado: (2016)

Aging‐Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation
por: Pastori, Daniele, et al.
Publicado: (2016)

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry
por: Pastori, Daniele, et al.
Publicado: (2019)

Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach
por: Pastori, Daniele, et al.
Publicado: (2019)

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease
por: Pastori, Daniele, et al.
Publicado: (2018)

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta‐Analysis
por: Violi, Francesco, et al.
Publicado: (2020)

Age-related increase of thromboxane B(2) and risk of cardiovascular disease in atrial fibrillation
por: Pastori, Daniele, et al.
Publicado: (2016)

Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study
por: Violi, Francesco, et al.
Publicado: (2015)

Gut‐Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet
por: Pastori, Daniele, et al.
Publicado: (2017)

Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?
por: Baratta, Francesco, et al.
Publicado: (2015)

Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
por: Biccirè, Flavio Giuseppe, et al.
Publicado: (2022)

Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study
por: Pastori, Daniele, et al.
Publicado: (2018)

Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality
por: Violi, Francesco, et al.
Publicado: (2021)

Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients
por: Armentaro, Giuseppe, et al.
Publicado: (2022)

Prevalence of new-onset atrial fibrillation in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis
por: Corica, Bernadette, et al.
Publicado: (2022)

Thrombosis in pre- and post-vaccination phase of COVID-19
por: Violi, Francesco, et al.
Publicado: (2021)

Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
por: Baratta, Francesco, et al.
Publicado: (2019)

Effect of corticosteroids on myocardial injury among patients hospitalized for community-acquired pneumonia: rationale and study design. The colosseum trial
por: Violi, Francesco, et al.
Publicado: (2019)

Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2015)

Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review
por: Violi, Francesco, et al.
Publicado: (2016)

Predictors of Renal Function Worsening in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Multicenter Observational Study
por: Pelaia, Corrado, et al.
Publicado: (2021)

Atrial fibrillation in pneumonia: what clinical implications at long-term?
por: Vitolo, Marco, et al.
Publicado: (2022)

NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease
por: Del Ben, Maria, et al.
Publicado: (2014)

Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis
por: Pastori, Daniele, et al.
Publicado: (2015)

PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation
por: Cammisotto, Vittoria, et al.
Publicado: (2020)

Mobile health-technology integrated care in secondary prevention atrial fibrillation patients: a post-hoc analysis from the mAFA-II randomized clinical trial
por: Guo, Yutao, et al.
Publicado: (2023)

Efficacy of mobile health-technology integrated care based on the ‘Atrial fibrillation Better Care’ (ABC) pathway in relation to sex: a report from the mAFA-II randomized clinical trial
por: Guo, Yutao, et al.
Publicado: (2023)

Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register
por: Poli, Daniela, et al.
Publicado: (2022)

Poor Adherence to Mediterranean Diet and Serum Lipopolysaccharide Are Associated with Oxidative Stress in Patients with Non-Alcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2020)

NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care
por: Portincasa, Piero
Publicado: (2023)

Envisioning simple equitable and mobile-health solutions for complex and diverse needs of women and men with atrial fibrillation
por: Raparelli, Valeria, et al.
Publicado: (2023)

Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register
por: Succurro, Elena, et al.
Publicado: (2023)

Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy
por: Di Costanzo, Alessia, et al.
Publicado: (2018)

Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management
por: Pignatelli, Pasquale, et al.
Publicado: (2020)

Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review
por: Coronati, Mattia, et al.
Publicado: (2022)

Screening for atrial fibrillation during automated blood pressure measurement among patients admitted to internal medicine ward
por: Pucci, Giacomo, et al.
Publicado: (2021)

Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines
por: Marcucci, Rossella, et al.
Publicado: (2021)

Efficacy and safety of direct oral anticoagulants in older adults with atrial fibrillation: a prospective single-centre cohort study
por: Catalani, Filippo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_308gjl4sli67pr8iv0bdt4ul7g